HIF1A and neoplasm: Direct inhibition of the HIF-1 pathway provides supporting evidence that removal of the hypoxia-induced immunosuppressive phenotype in the tumour microenvironment could improve the immune cell profile in the tumour, potentially boosting immunotherapy response.